Frontline Therapy

(31:32)

Frontline Therapy in Melanoma

(3:50)

Maintenance and Frontline Therapy in CLL

(5:26)

Frontline Therapy Project

(30:55)

Frontline Therapy for Polycythemia Vera

(5:54)

Unresectable HCC: Considerations for Resection and Frontline Therapy

(3:50)

How frontline therapy impacts the management of patients with ALL prior to CAR-T

(1:9)

First-Line or Frontline Therapy Options In Multiple Myeloma | 2023 IMF Patient and Family Seminar

(57:52)

Advances in Frontline Therapy for CLL

(4:42)

Frontline therapy for multiple myeloma

(1:27)

Choosing Frontline Therapy for Mantle Cell Lymphoma

(5:42)

NALIRIFOX as frontline therapy for PDAC

(1:28)

Frontline Therapy Project

(34:43)

Tian Zhang on Frontline Therapy in RCC

(1:49)

Selecting the Optimal Frontline Therapy in CLL

(4:20)

Frontline Therapy for mCRC

(8:42)

Dr. Wierda on Frontline Therapy for Older CLL Patients Compared to Younger

(2:13)

Frontline Therapy Options for Stage IV Ovarian Cancer

(3:34)

Frontline Therapy Advances for Multiple Myeloma Patients | ASH 2024 Insights for Patients

(3:8)

CLL14: feasibility of fixed-duration frontline therapy in CLL

(1:32)